Back to Search
HUIQING YANG, M.D.
M.D.
Physical Medicine & Rehabilitation Physician
NPI: 1710271234Individual
Specialties, Licenses & Credentials
Physical Medicine & Rehabilitation PhysicianPrimary
Physical Medicine & Rehabilitation
Code: 208100000X
Q2223(TX)
Research & Publications (20)
Tubulin isotype specificity and identification of the epitope for antibody Tub 2.1.
PMID 19625384·Protein Eng Des Sel·2009
7-preclinical
Residual DNA methylation at remission is prognostic in adult Philadelphia chromosome-negative acute lymphocytic leukemia.
PMID 19109226·Blood·2009
8-other
Genetic polymorphisms in double-strand break DNA repair genes associated with risk of oral premalignant lesions.
PMID 18579371·Eur J Cancer·2008
8-other
Profiling of genetic variations in inflammation pathway genes in relation to bladder cancer predisposition.
PMID 18381966·Clin Cancer Res·2008
8-other
Evaluation of genetic variants in microRNA-related genes and risk of bladder cancer.
PMID 18381463·Cancer Res·2008
8-other
Heightened sensitivity to paclitaxel in Class IVa beta-tubulin-transfected cells is lost as expression increases.
PMID 17627938·J Biol Chem·2007
7-preclinical
ATM sequence variants associate with susceptibility to non-small cell lung cancer.
PMID 17582598·Int J Cancer·2007
8-other
Roles for negative cell regulator 14-3-3sigma in control of MDM2 activities.
PMID 17546054·Oncogene·2007
7-preclinical
DNA damage-induced protein 14-3-3 sigma inhibits protein kinase B/Akt activation and suppresses Akt-activated cancer.
PMID 16540659·Cancer Res·2006
7-preclinical
Negative cell cycle regulator 14-3-3sigma stabilizes p27 Kip1 by inhibiting the activity of PKB/Akt.
PMID 16532026·Oncogene·2006
7-preclinical
14-3-3sigma, a p53 regulator, suppresses tumor growth of nasopharyngeal carcinoma.
PMID 16505098·Mol Cancer Ther·2006
7-preclinical
A novel triple purge strategy for eliminating chronic myelogenous leukemia (CML) cells from autografts.
PMID 16435011·Bone Marrow Transplant·2006
8-other
Modified p27 Kip1 is efficient in suppressing HER2-mediated tumorigenicity.
PMID 16365885·J Cell Biochem·2006
7-preclinical
Functional interaction between RNA helicase II/Gu(alpha) and ribosomal protein L4.
PMID 16045751·FEBS J·2005
7-preclinical
C-reactive protein decreases expression of VEGF receptors and neuropilins and inhibits VEGF165-induced cell proliferation in human endothelial cells.
PMID 15975559·Biochem Biophys Res Commun·2005
8-other
Antileukemia activity of the combination of 5-aza-2'-deoxycytidine with valproic acid.
PMID 15927669·Leuk Res·2005
8-other
Constitutively active FOXO4 inhibits Akt activity, regulates p27 Kip1 stability, and suppresses HER2-mediated tumorigenicity.
PMID 15688030·Oncogene·2005
7-preclinical
Effects of cyclophilin A on cell proliferation and gene expressions in human vascular smooth muscle cells and endothelial cells.
PMID 15680395·J Surg Res·2005
8-other
Expression and regulation of neuropilins and VEGF receptors by TNF-alpha in human endothelial cells.
PMID 15555625·J Surg Res·2004
8-other
14-3-3 sigma positively regulates p53 and suppresses tumor growth.
PMID 14517281·Mol Cell Biol·2003
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2727 W HOLCOMBE BLVD, 4TH FLOOR, OPTOMETRY
HOUSTON, TX 77025 - Phone
- (713) 442-0000
Quick Facts
- NPI
- 1710271234
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile